NORepinephrine Bitartrate 0 recalled over manufacturing violations
- Recall date
- September 25, 2024
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- Fresenius Kabi Compounding, LLC recalls NORepinephrine Bitartrate 0.9% Sodium Chloride Injection USP, 8 mg per 250 mL, Single Dose Bag, Rx only, Fagron Sterile…
- Recall number
- D-0020-2025
- FDA classification
- Class II
- Brand / firm
- Fresenius Kabi Compounding, LLC
- Sold / distributed
- Product was distributed to 125 direct accounts nationwide.
Why it was recalled
cGMP violations
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
NORepinephrine Bitartrate 0.9% Sodium Chloride Injection USP, 8 mg per 250 mL, Single Dose Bag, Rx only, Fagron Sterile Services, Canton, MA NDC: 71506-027-58
Get recall alerts
Free email alert whenever Fresenius Kabi Compounding, LLC has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Fresenius Kabi Compounding, LLC